A New Modality
Exosome therapeutics opens the door to an entirely new way to address a vast range of illnesses.
Codiak’s proprietary engEx™ technology platform for exosome engineering and manufacturing represents a transformative step in the treatment of disease, enabling the development of therapies for diseases that are currently considered intractable. Using this breakthrough platform, we can produce tailor-made drug candidates and make them at industrial quality and scale.
Broad Pipeline Potential
Using our engEx™ Platform, Codiak is developing a proprietary pipeline of novel, targeted medicines for diseases with high unmet medical need. Beginning with oncology, we are exploring the significant potential of this versatile and precise approach to engineering exosomes to address a broad range of disease areas.